All research
2026-04-03 PubMed

COVID-19 convalescent patient continues shedding SARS-CoV-2 RNA in stool for 24 days post-respiratory clearance.

A Convalescent of COVID-19 with RT-PCR Test Continues Positive in Stool.

Background

Coronavirus disease (COVID-19) rapidly became a global pandemic, necessitating robust discharge criteria for infected patients to prevent further transmission. In China, standard discharge protocols for COVID-19 patients required two consecutive negative respiratory viral RNA tests, typically via RT-PCR, at least one day apart, with no routine testing of fecal samples. This approach, however, overlooked the potential for gastrointestinal viral persistence, creating a critical gap in understanding and mitigating post-discharge transmission risks from SARS-CoV-2. The current study highlights this overlooked pathway.

Study Design

Researchers presented a single COVID-19 patient whose respiratory swabs became negative for SARS-CoV-2 RNA, but whose fecal sample remained positive. The patient's clinical course was monitored, with RT-PCR testing performed on both respiratory and stool samples. The primary objective was to track the persistence of viral RNA in different sample types following initial respiratory clearance. The study focused on the duration of SARS-CoV-2 RNA positivity in stool after the patient met the respiratory discharge criteria, providing a unique observation of viral shedding dynamics.

Results

The patient's respiratory swabs for SARS-CoV-2 RNA became negative, meeting the standard discharge criteria. However, subsequent RT-PCR testing of stool samples revealed persistent viral shedding.

Stool samples collected on the 27th of February were still positive for SARS-CoV-2 RNA, a remarkable 24 days after the first negative respiratory swab result. This finding demonstrates that SARS-CoV-2 can persist and be shed via the gastrointestinal tract for an extended period, even after the respiratory system has cleared the virus. The continued presence of viral RNA in feces suggests a prolonged potential for environmental contamination and fecal-oral transmission, challenging the adequacy of respiratory-only discharge protocols.

Key Findings

  • A COVID-19 patient continued to test positive for SARS-CoV-2 RNA in stool.
  • Fecal viral RNA persistence was observed for 24 days after respiratory swabs became negative.
  • Current respiratory-only discharge criteria may overlook gastrointestinal viral shedding.
  • Fecal SARS-CoV-2 RNA testing is recommended for discharge criteria to minimize transmission risk.

Why It Matters

This case report critically highlights that current COVID-19 discharge criteria, relying solely on respiratory viral clearance, may be insufficient to prevent community transmission. Incorporating fecal RNA testing for SARS-CoV-2 into discharge protocols could significantly minimize the risk of transmission from the gastrointestinal tract, especially given the known fecal-oral transmission potential of coronaviruses, as observed in the 2003 SARS epidemic. For public health, this suggests a need for updated guidelines to ensure patients are truly non-infectious before discharge, potentially impacting quarantine durations and post-recovery monitoring. This finding underscores the importance of a holistic approach to viral clearance assessment.


covid-19 sars-cov-2 viral-shedding fecal-transmission rt-pcr case-report
Source: pubmed:33337843 · Ingested 2026-04-03 · Digest: gemini-2.5-flash